OverviewSuggest Edit

Apyx Medical (formerly known as Bovie Medical) is an advanced energy technology company providing products in the cosmetic and surgical markets. Its products include Renuvion cosmetic technology and J-Plasma, helium plasma technology.
TypePublic
HQClearwater, FL, US
Websiteapyxmedical.com
Employee Ratings2.2

Latest Updates

Employees (est.) (Dec 2019)266(+20%)
Job Openings5
Revenue (FY, 2020)$27.7 M(-1%)
Share Price (Oct 2021)$13.3
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Apyx Medical

Charles D. Goodwin

Charles D. Goodwin

President and Chief Executive Officer, Director
Moshe Citronowicz

Moshe Citronowicz

Senior Vice President
Lawrence J. Waldman

Lawrence J. Waldman

Director
Minnie Baylor-Henry

Minnie Baylor-Henry

Director
Tara Semb

Tara Semb

Chief Financial Officer
Show more

Apyx Medical Office Locations

Apyx Medical has an office in Clearwater
Clearwater, FL, US (HQ)
5115 Ulmerton Rd
Show all (1)

Apyx Medical Financials and Metrics

Apyx Medical Revenue

Apyx Medical's revenue was reported to be $27.71 m in FY, 2020
USD

Revenue (Q1, 2021)

8.6m

Gross profit (Q1, 2021)

5.9m

Gross profit margin (Q1, 2021), %

67.8%

Net income (Q1, 2021)

(4.9m)

EBIT (Q1, 2021)

(4.7m)

Market capitalization (18-Oct-2021)

454.7m

Closing stock price (18-Oct-2021)

13.3

Cash (31-Mar-2021)

39.5m

EV

415.5m
Apyx Medical's current market capitalization is $454.7 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

25.4m27.7m27.7m29.5m36.6m38.9m16.7m28.2m27.7m

Cost of goods sold

14.7m16.3m18.7m17.0m18.7m19.1m5.9m9.1m10.2m

Gross profit

10.7m11.3m9.0m12.6m17.9m19.8m10.8m19.1m17.5m

Gross profit Margin, %

42%41%32%43%49%51%65%68%63%
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

6.8m6.3m6.7m7.4m6.7m5.7m6.0m5.8m6.5m6.9m6.8m6.1m7.3m7.8m7.8m9.3m10.1m8.4m9.8m9.3m9.9m11.5m3.7m5.6m6.6m7.6m5.0m4.3m8.6m

Cost of goods sold

3.8m3.7m3.9m4.6m3.8m3.5m3.8m3.5m3.7m5.1m4.9m3.5m4.1m4.6m4.5m4.6m5.0m4.2m4.8m4.8m4.9m5.2m1.2m2.1m2.1m2.6m2.0m2.2m2.8m

Gross profit

3.0m2.6m2.8m2.9m2.9m2.2m2.2m2.2m2.8m1.9m1.9m2.7m3.1m3.2m3.3m4.7m5.1m4.2m5.0m4.6m5.0m6.3m2.5m3.6m4.5m5.0m3.0m2.1m5.9m

Gross profit Margin, %

45%42%42%38%43%38%37%39%43%27%28%44%43%41%43%51%50%50%51%49%50%55%69%63%68%66%60%49%68%
USDQ2, 2011

Financial Leverage

1.3 x
Show all financial metrics

Apyx Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Apyx Medical Online and Social Media Presence

Embed Graph

Apyx Medical News and Updates

Cold Plasma Equipment Market To Observe Exponential Growth By 2020-2027| Tantec, Europlasma NV, Adtec Healthcare, Plasmatreat, Apyx Medical

The cold plasma equipment market was valued at US$ 96.67 million in 2019 and is expected to grow at a CAGR of 15.6% from 2020to2027 to reach US$ 308.87 million by 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday

WeissLaw LLP: Apyx Medical Corporation is the Subject of a Legal Investigation

NEW YORK, July 30, 2020 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, California and Georgia, announces an investigation of Apyx Medical Corporation (NASDAQ: APYX) ("Apyx Medical Corp.," or the "Company"). If you own Apyx...

Kaskela Law LLC Announces Investigation of Apyx Medical Corp. (APYX) and Encourages Long-Term APYX Stockholders to Contact the Firm

PHILADELPHIA, June 6, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Apyx Medical Corporation (NASDAQ: APYX) ("Apyx" or the "Company") on behalf of the Company's stockholders. In September 2019, a securities fraud complaint was filed against Apyx in federal court...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX

NEW YORK, April 12, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...

APYX MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apyx Medical Corporation - APYX

NEW ORLEANS, March 27, 2020 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Apyx Medical Corporation (NasdaqGS: APYX). On December 21,...

Apyx Medical Blogs

APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON NOVEMBER 11, 2021

The post APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON NOVEMBER 11, 2021 appeared first on Apyx Medical.

APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF WENDY LEVINE TO THE COMPANY’S BOARD OF DIRECTORS

The post APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF WENDY LEVINE TO THE COMPANY’S BOARD OF DIRECTORS appeared first on Apyx Medical.

APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOK

The post APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOK appeared first on Apyx Medical.

APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON AUGUST 12, 2021

The post APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON AUGUST 12, 2021 appeared first on Apyx Medical.

APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCE

The post APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCE appeared first on Apyx Medical.

APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURES

The post APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURES appeared first on Apyx Medical.
Show more

Apyx Medical Frequently Asked Questions

  • Who are Apyx Medical key executives?

    Apyx Medical's key executives are Charles D. Goodwin, Moshe Citronowicz and Lawrence J. Waldman.

  • How many employees does Apyx Medical have?

    Apyx Medical has 266 employees.

  • What is Apyx Medical revenue?

    Latest Apyx Medical annual revenue is $27.7 m.

  • What is Apyx Medical revenue per employee?

    Latest Apyx Medical revenue per employee is $104.2 k.

  • Who are Apyx Medical competitors?

    Competitors of Apyx Medical include SMC, Breas Medical and QuantuMDx.

  • Where is Apyx Medical headquarters?

    Apyx Medical headquarters is located at 5115 Ulmerton Rd, Clearwater.

  • Where are Apyx Medical offices?

    Apyx Medical has an office in Clearwater.

  • How many offices does Apyx Medical have?

    Apyx Medical has 1 office.